10-Q: Richardson Electronics Reports Q3 Fiscal 2025 Results: Sales Up, Healthcare Asset Sale Impacts Bottom Line

Richardson Electronics reports a slight increase in net sales but a net loss for Q3 fiscal 2025, primarily due to the sale of its Healthcare assets.

Summary

• Richardson Electronics' net sales for Q3 fiscal 2025 increased by 2.7% to $53.8 million compared to $52.4 million in Q3 fiscal 2024.
• The company reported a net loss of $2.1 million for Q3 fiscal 2025, compared to a net income of $0.8 million in Q3 fiscal 2024.
• The loss is primarily attributed to a $4.9 million loss from the disposal of certain Healthcare assets.
• Gross margin increased to 31.0% in Q3 fiscal 2025 from 29.5% in Q3 fiscal 2024.
• For the first nine months of fiscal 2025, net sales increased by 5.3% to $157.0 million compared to $149.1 million in the same period of fiscal 2024.
• The company reported a net loss of $2.2 million for the first nine months of fiscal 2025, compared to a net income of $0.2 million in the first nine months of fiscal 2024.
• Gross margin for the first nine months of fiscal 2025 was 30.8%, up from 30.3% in the prior year period.
• Selling, general, and administrative expenses were $14.5 million in Q3 fiscal 2025 and $46.6 million for the first nine months of fiscal 2025.
• As of March 1, 2025, cash and cash equivalents totaled $36.7 million.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While sales increased slightly, the net loss due to the Healthcare asset sale offsets the positive aspects. The company is undergoing a strategic shift, which introduces both opportunities and uncertainties.

Positives

• Net sales increased by 2.7% in Q3 fiscal 2025.
• Gross margin improved to 31.0% in Q3 fiscal 2025.
• PMT sales increased 6.6% in Q3 fiscal 2025, driven by engineered solutions for the semiconductor market.
• Canvys sales increased 39.5% in Q3 fiscal 2025, driven by North American markets.
• Gross margin for the first nine months of fiscal 2025 was 30.8%, up from 30.3% in the prior year period.

Negatives

• The company experienced a net loss of $2.1 million in Q3 fiscal 2025.
• A $4.9 million loss was recorded due to the disposal of Healthcare assets.
• GES sales decreased 19.4% in Q3 fiscal 2025 due to the project-based nature of the segment and a shipping delay.
• Healthcare sales decreased 32.3% in Q3 fiscal 2025 due to the sale of the majority of Healthcare assets to DirectMed.

Risks

• Economic pressures related to inflation, rising interest rates, economic weakness or recession, geopolitical and public health issues, tightening labor markets, and pandemics could disrupt operations.
• Tariffs on products manufactured in China and imported into the United States could negatively affect sales and gross margins if the company is unable to pass through the additional cost or if higher prices reduce demand.

Future Outlook

The company will continue manufacturing ALTA CT X-ray tubes for DirectMed for approximately 12 to 18 months.

Industry Context

The company serves various industries including alternative energy, healthcare, aviation, broadcast, communications, industrial, marine, medical, military, scientific, and semiconductor markets, indicating a diversified business model.

Comparison to Industry Standards

• It is difficult to compare Richardson Electronics directly to industry standards without knowing the specific performance metrics of its direct competitors in each of its segments (PMT, GES, Canvys).
• However, the semiconductor market is experiencing growth, which is reflected in the increased sales in the PMT segment.
• The green energy sector is also expanding, which is evident in the increased sales in the GES segment.
• The healthcare segment's performance is impacted by the sale of assets, making a direct comparison challenging.
• Comparable companies in the electronic components distribution industry include Arrow Electronics and Avnet, but their diversified product portfolios make direct comparisons limited.

Stakeholder Impact

• Shareholders will be impacted by the net loss reported for the quarter.
• Employees in the Healthcare segment were likely impacted by the sale of assets to DirectMed.
• Customers in the Healthcare market will now be served by DirectMed for certain products and services.
• Suppliers may be affected by the changes in the Healthcare segment.

Next Steps

• The company will continue to execute its strategy of providing specialized technical expertise and engineered solutions.
• Richardson will supply DirectMed with repaired Siemens CT X-ray tubes under an exclusive 10-year global supply agreement.
• The company will continue manufacturing ALTA CT X-ray tubes for DirectMed for approximately 12 to 18 months.

Key Dates

Keywords

Richardson Electronics, financial results, Q3 2025, healthcare asset sale, net sales, gross margin, net loss, PMT, GES, Canvys, DirectMed, engineered solutions, green energy, display solutions